PTHS (Pelthos Therapeutics) Institutional Ownership: 28.41% (As of Jul. 08, 2026)


PTHS Pelthos Therapeutics Inc PTHS
8 GF Score
Price $26.45
! 4 Warning Signs
View Full Analysis

What is Pelthos Therapeutics Institutional Ownership?

Pelthos Therapeutics PTHS +7.50% 8 Institutional Ownership is 28.41% as of Jul. 08, 2026. GuruFocus rates PTHS with a GF Score™ of 8/100. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pelthos Therapeutics's institutional ownership is 28.41%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pelthos Therapeutics's Insider Ownership is 12.52%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pelthos Therapeutics's Float Percentage Of Total Shares Outstanding is 49.25%.

Pelthos Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Pelthos Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pelthos Therapeutics Institutional Ownership Chart

Pelthos Therapeutics Historical Data

The historical data trend for Pelthos Therapeutics can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 10.70 11.56 4.00 3.85 3.90 4.71 4.69 4.69 4.54 4.66
PTHS
8GF Score
Pelthos Therapeutics Inc PTHS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pelthos Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 28.41% mean?
Pelthos Therapeutics (PTHS) has a Institutional Ownership of 28.41% as of Jul. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Pelthos Therapeutics and its competitors.
Is Pelthos Therapeutics' Institutional Ownership too high?
Pelthos Therapeutics' current Institutional Ownership is 28.41%. Overall, Pelthos Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Pelthos Therapeutics' Institutional Ownership compare to CGTX and BDTX?
Pelthos Therapeutics' Institutional Ownership of 28.41% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Pelthos Therapeutics and its competitors. Pelthos Therapeutics's current Institutional Ownership is 28.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pelthos Therapeutics stock overvalued right now?
Pelthos Therapeutics (PTHS) has a current Institutional Ownership of 28.41%. The current Institutional Ownership is 28.41%. Pelthos Therapeutics' overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Pelthos Therapeutics (PTHS), the current Institutional Ownership is 28.41% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pelthos Therapeutics Business Description

Address 4020 Stirrup Creek Drive, Suite 110, Durham, NC, USA, 27703
Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens. The Company currently has three U.S. Food and Drug Administration (FDA) approved products in its commercial portfolio, in various stages of commercialization, including ZELSUVMITM, XEPI, and XEGLYZE. The company operates in two reporting segments: the sale, promotion, and commercialization of approved commercial products, the Commercial Operations segment, and research and development activities related to developing a novel and proprietary class of NaV blockers that target the body's peripheral nervous system; and supportive activities to expand the NITRICIL nitric oxide-based technology.
8GF Score

Get the complete analysis for PTHS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.45
Price